Evidence map›Paper›PMID 33818671›Full record

ArticleApplied microbiology and biotechnology2021

Low cost and sustainable hyaluronic acid production in a manufacturing platform based on Bacillus subtilis 3NA strain.

Sebastián Cerminati, Mélanie Leroux, Pablo Anselmi, Salvador Peirú, Juan C Alonso, Bernard Priem, Hugo G Menzella

Erratum issuedOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Prospective bacterial and fungal sources of hyaluronic acid: A review.Computational and structural biotechnology journal · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Sebastián CerminatiInstituto de Procesos Biotecnológicos y Químicos (IPROBYQ), Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), CONICET, Suipacha 570, S2002LRL, Rosario, Argentina. cerminati@iprobyq-conicet.gob.ar.ORCID http://orcid.org/0000-0002-0883-1277
Mélanie LerouxCentre de Recherches sur les Macromolécules Végétales, CNRS, Université Grenoble Alpes, 38041, Grenoble, France.
Pablo AnselmiInstituto de Procesos Biotecnológicos y Químicos (IPROBYQ), Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), CONICET, Suipacha 570, S2002LRL, Rosario, Argentina.
Salvador PeirúInstituto de Procesos Biotecnológicos y Químicos (IPROBYQ), Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), CONICET, Suipacha 570, S2002LRL, Rosario, Argentina.
Juan C AlonsoDepartment of Microbial Biotechnology, Centro Nacional de Biotecnología, CNB-CSIC, 28049, Madrid, Spain.
Bernard PriemCentre de Recherches sur les Macromolécules Végétales, CNRS, Université Grenoble Alpes, 38041, Grenoble, France.
Hugo G MenzellaInstituto de Procesos Biotecnológicos y Químicos (IPROBYQ), Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario (UNR), CONICET, Suipacha 570, S2002LRL, Rosario, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARCentre National de la Recherche Scientifique · FRCentro Nacional de Biotecnología · ESNational University of Rosario · AR

Funding

Glyco@Alps ANR-15-IDEX-02
6 · The paper itself

Abstract

Hyaluronic acid (HA) is a high value glycosaminoglycan mostly used in health and cosmetic applications. Commercial HA is produced from animal tissues or in toxigenic bacteria of the genus Streptococcus grown in complex media, which are expensive and raise environmental concerns due to the disposal of large amounts of broth with high organic loads. Other microorganisms were proposed as hosts for the heterologous production of HA, but the methods are still costly. The extraordinary capacity of this biopolymer to bind and retain water attracts interest for large-scale applications where biodegradable materials are needed, but its high cost and safety concerns are barriers for its adoption. Bacillus subtilis 3NA strain is prototrophic, amenable for genetic manipulation, GRAS, and can rapidly reach high cell densities in salt-based media. These phenotypic traits were exploited to create a platform for biomolecule production using HA as a proof of concept. First, the 3NA strain was engineered to produce HA; second, a chemically defined medium was formulated using commodity-priced inorganic salts combined at the stoichiometric ratios needed to build the necessary quantities of biomass and HA; and third, a scalable fermentation process, where HA can be produced at the maximum volumetric productivity (VP), was designed. A comparative economic analysis against other methods indicates that the new process may increase the operating profit of a manufacturing plant by more than 100%. The host, the culture medium, and the rationale employed to develop the fermentation process described here, introduce an IP-free platform that could be adaptable for production of other biomolecules. KEY POINTS: • A biomolecule production platform based on B. subtilis 3NA strain and a synthetic medium was tested for hyaluronic acid biosynthesis • A fermentation process with the maximum volumetric productivity was designed • A techno-economic analysis forecasts a significant reduction in the manufacturing cost compared to the current methods.

Indexed as

Bacillus subtilisHyaluronic AcidAnimalsCulture MediaFermentationStreptococcusCulture MediaHyaluronic AcidBacillus subtilisFermentationGreen chemistryHyaluronic acid

Identifiers

PMID33818671
OpenAlexW3149065164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.